Sunday, 1 March 2015

Adjuvant VEGF Blockers Disappoint in Kidney Cancer

(MedPage Today) -- Survival no better with post-surgical sunitinib or sorafenib than with placebo. via MedPageToday.com - medical news plus CME for physicians Read More Here..
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)